88 related articles for article (PubMed ID: 20436347)
1. About a case of diffuse endometrial squamous metaplasia after resectoscopic myomectomy: a potential diagnostic pitfall for gynecologists and pathologists.
Amico P; Caltabiano R; Zizza G; Lanzafame S
Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):392-5. PubMed ID: 20436347
[TBL] [Abstract][Full Text] [Related]
2. Endometrial hyperplasia with berrylike squamous metaplasia and pilomatrixomalike shadow cells. Report of an intriguing cytohistologic case.
Blandamura S; Boccato P; Spadaro M; Litta P; Chiarelli S
Acta Cytol; 2002; 46(5):887-92. PubMed ID: 12365225
[TBL] [Abstract][Full Text] [Related]
3. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
4. Simple and complex hyperplastic papillary proliferations of the endometrium: a clinicopathologic study of nine cases of apparently localized papillary lesions with fibrovascular stromal cores and epithelial metaplasia.
Lehman MB; Hart WR
Am J Surg Pathol; 2001 Nov; 25(11):1347-54. PubMed ID: 11684950
[TBL] [Abstract][Full Text] [Related]
5. Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data.
Agorastos T; Bontis J; Vakiani A; Vavilis D; Constantinidis T
Gynecol Oncol; 1997 Apr; 65(1):102-14. PubMed ID: 9103399
[TBL] [Abstract][Full Text] [Related]
6. Endometrial metaplasia associated with endometrial carcinoma.
Kaku T; Tsukamoto N; Tsuruchi N; Sugihara K; Kamura T; Nakano H
Obstet Gynecol; 1992 Nov; 80(5):812-6. PubMed ID: 1407921
[TBL] [Abstract][Full Text] [Related]
7. GnRH agonists before surgery for uterine leiomyomas. A review.
Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
[TBL] [Abstract][Full Text] [Related]
8. [Endometrial atypical complex hyperplasia with extensive squamous metaplasia: two cases].
Hannachi Sassi S; Dhouib R; Abbes I; Braham E; Mrad K; Driss M; Ben Hamida N; Ben Romdhane K
Ann Pathol; 2008 Jun; 28(3):233-6. PubMed ID: 18706369
[TBL] [Abstract][Full Text] [Related]
9. GnRH agonist therapy before myomectomy or hysterectomy.
Gutmann JN; Corson SL
J Minim Invasive Gynecol; 2005; 12(6):529-37; quiz 528, 538-9. PubMed ID: 16337584
[No Abstract] [Full Text] [Related]
10. Gonadotropin releasing hormone agonist and levonorgestrel-intrauterine device followed by in vitro fertilization program as management strategy for an infertile endometrial cancer patient: a case report.
Nucera G; Mandato VD; Gelli MC; Palomba S; La Sala GB
Gynecol Endocrinol; 2013 Mar; 29(3):219-21. PubMed ID: 23153053
[TBL] [Abstract][Full Text] [Related]
11. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (leuprolide acetate).
Mizutani T; Sugihara A; Nakamuro K; Terada N
J Clin Endocrinol Metab; 1998 Apr; 83(4):1253-5. PubMed ID: 9543151
[TBL] [Abstract][Full Text] [Related]
12. Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.
Mizutani T; Sugihara A; Honma H; Komura H; Nakamuro K; Terada N
Gynecol Endocrinol; 2005 Feb; 20(2):80-3. PubMed ID: 15823826
[TBL] [Abstract][Full Text] [Related]
13. The combined GnRH-agonist and intrauterine levonorgestrel-releasing system treatment of complicated atypical hyperplasia and endometrial cancer: a pilot study.
Pashov AI; Tskhay VB; Ionouchene SV
Gynecol Endocrinol; 2012 Jul; 28(7):559-61. PubMed ID: 22296608
[TBL] [Abstract][Full Text] [Related]
14. Potential cost savings using GnRH agonists as preoperative therapy for uterine leiomyomas.
Saltiel E
Formulary; 1995 Sep; 30(9):532-4, 542. PubMed ID: 10161243
[TBL] [Abstract][Full Text] [Related]
15. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.
Edris F; Vilos GA; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
J Minim Invasive Gynecol; 2007; 14(1):68-73. PubMed ID: 17218233
[TBL] [Abstract][Full Text] [Related]
16. Endometrial squamous metaplasia. An unusual response to progestin therapy of hyperplasia.
Miranda MC; Mazur MT
Arch Pathol Lab Med; 1995 May; 119(5):458-60. PubMed ID: 7748076
[TBL] [Abstract][Full Text] [Related]
17. [Methods and efficacy of medical and surgical treatment of non functional menorrhagia].
Brun JL; André G; Descat E; Creux H; Vigier J; Dallay D
J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S368-83. PubMed ID: 19268216
[TBL] [Abstract][Full Text] [Related]
18. Immature squamous metaplasia of esophageal glands associated with squamous cell carcinoma.
Verset L; Huberty V; Bourgeois V; Lemmers A; Demetter P
Acta Gastroenterol Belg; 2022; 85(2):396-399. PubMed ID: 35709785
[TBL] [Abstract][Full Text] [Related]
19. Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma.
Zaino RJ; Kurman RJ
Semin Diagn Pathol; 1988 May; 5(2):154-71. PubMed ID: 3041509
[TBL] [Abstract][Full Text] [Related]
20. Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.
Williams AR; Bergeron C; Barlow DH; Ferenczy A
Int J Gynecol Pathol; 2012 Nov; 31(6):556-69. PubMed ID: 23018219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
